Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for weight management in obese or overweight Chinese adults without diabetes
CTR20201274Phase 3Completed
- Sponsor
- Jiuyuan Gene Engineering
- Start
- Jun 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in obesity, Overweight, sponsored by Jiuyuan Gene Engineering. Started Jun 2020; status: completed.
02
Drugs
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20201274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201274.